Six HMS early career investigators received NIH Director’s New Innovator Awards from the National Institutes of Health. Part of the NIH’s High-Risk, High-Reward Research program, the award supports investigators who propose innovative research that, due to its inherent risk, may struggle within the traditional NIH peer-review process despite its transformative potential.
The New Innovator Award supports unusually innovative research from early career investigators who are within 10 years of their final degree or clinical residency and have not yet received an NIH R01 or equivalent grant.
“The science advanced by these researchers is poised to blaze new paths of discovery in human health,” said Lawrence Tabak, the current acting director of NIH. “This unique cohort of scientists will transform what is known in the biological and behavioral world. We are privileged to support this innovative science.”